ES505037A0 - Procedimiento para la preparacion de derivados de aminotio- les - Google Patents
Procedimiento para la preparacion de derivados de aminotio- lesInfo
- Publication number
- ES505037A0 ES505037A0 ES505037A ES505037A ES505037A0 ES 505037 A0 ES505037 A0 ES 505037A0 ES 505037 A ES505037 A ES 505037A ES 505037 A ES505037 A ES 505037A ES 505037 A0 ES505037 A0 ES 505037A0
- Authority
- ES
- Spain
- Prior art keywords
- aminotiol
- derivatives
- procedure
- preparation
- aminotiol derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU82738A LU82738A1 (fr) | 1980-08-29 | 1980-08-29 | Derives d'aminothiols,leur preparation et utilisation ainsi que compositions contenant ces derives |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8307735A1 ES8307735A1 (es) | 1983-08-16 |
ES505037A0 true ES505037A0 (es) | 1983-08-16 |
Family
ID=19729472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES505037A Granted ES505037A0 (es) | 1980-08-29 | 1981-08-28 | Procedimiento para la preparacion de derivados de aminotio- les |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5798255A (fr) |
AU (1) | AU7465481A (fr) |
BE (1) | BE890116A (fr) |
DE (1) | DE3133293A1 (fr) |
DK (1) | DK382281A (fr) |
ES (1) | ES505037A0 (fr) |
FI (1) | FI812640L (fr) |
FR (1) | FR2489325A1 (fr) |
GB (1) | GB2083036A (fr) |
GR (1) | GR74348B (fr) |
IL (1) | IL63664A0 (fr) |
IT (1) | IT1137642B (fr) |
LU (1) | LU82738A1 (fr) |
NL (1) | NL8103993A (fr) |
NO (1) | NO812944L (fr) |
PT (1) | PT73593B (fr) |
SE (1) | SE8104958L (fr) |
ZA (1) | ZA815912B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8405896D0 (en) * | 1984-03-07 | 1984-04-11 | Sandoz Ltd | Organic compounds |
US4638051A (en) * | 1984-04-30 | 1987-01-20 | The Johns Hopkins University | Brain imaging radiopharmaceuticals |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2505870A (en) * | 1947-05-09 | 1950-05-02 | Phillips Petroleum Co | Secondary and tertiary alkylthiol amines and their production |
US3337625A (en) * | 1961-09-18 | 1967-08-22 | Lilly Co Eli | Amino-acetylenic compounds |
US3312732A (en) * | 1962-02-28 | 1967-04-04 | Monsanto Res Corp | Aminoalkyl aminoalkanethiols |
US3356730A (en) * | 1964-11-25 | 1967-12-05 | Monsanto Res Corp | Mercaptoalkyl oxyalkyl amines |
GB1138738A (en) * | 1966-12-01 | 1969-01-01 | Eastman Kodak Co | Aziridine derivatives |
US3622676A (en) * | 1968-11-20 | 1971-11-23 | Constance Anthony D Alonzo | Smoking suppression |
CA992105A (en) * | 1970-03-26 | 1976-06-29 | Exxon Research And Engineering Company | Polythioethers formed by anionic ring opening of episulfides |
BE789629A (fr) * | 1971-10-05 | 1973-04-03 | Sandoz Sa | Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique |
CH632906A5 (en) * | 1976-08-09 | 1982-11-15 | Givaudan & Cie Sa | Use of bifunctional N,S-compounds as flavourings |
-
1980
- 1980-08-29 LU LU82738A patent/LU82738A1/fr unknown
-
1981
- 1981-08-21 SE SE8104958A patent/SE8104958L/xx not_active Application Discontinuation
- 1981-08-22 DE DE19813133293 patent/DE3133293A1/de not_active Withdrawn
- 1981-08-24 IT IT23611/81A patent/IT1137642B/it active
- 1981-08-26 FI FI812640A patent/FI812640L/fi not_active Application Discontinuation
- 1981-08-26 ZA ZA815912A patent/ZA815912B/xx unknown
- 1981-08-26 AU AU74654/81A patent/AU7465481A/en not_active Abandoned
- 1981-08-26 IL IL63664A patent/IL63664A0/xx unknown
- 1981-08-27 NL NL8103993A patent/NL8103993A/nl not_active Application Discontinuation
- 1981-08-27 BE BE0/205790A patent/BE890116A/fr not_active IP Right Cessation
- 1981-08-27 JP JP56134793A patent/JPS5798255A/ja active Pending
- 1981-08-27 GR GR65879A patent/GR74348B/el unknown
- 1981-08-28 FR FR8116512A patent/FR2489325A1/fr not_active Withdrawn
- 1981-08-28 ES ES505037A patent/ES505037A0/es active Granted
- 1981-08-28 PT PT73593A patent/PT73593B/fr unknown
- 1981-08-28 DK DK382281A patent/DK382281A/da not_active Application Discontinuation
- 1981-08-28 NO NO812944A patent/NO812944L/no unknown
- 1981-08-28 GB GB8126304A patent/GB2083036A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
SE8104958L (sv) | 1982-03-01 |
GR74348B (fr) | 1984-06-26 |
LU82738A1 (fr) | 1982-05-10 |
DE3133293A1 (de) | 1982-04-08 |
AU7465481A (en) | 1982-03-04 |
DK382281A (da) | 1982-03-01 |
ES8307735A1 (es) | 1983-08-16 |
FR2489325A1 (fr) | 1982-03-05 |
FI812640L (fi) | 1982-03-01 |
IT8123611A0 (it) | 1981-08-24 |
PT73593B (fr) | 1982-11-10 |
ZA815912B (en) | 1982-08-25 |
PT73593A (fr) | 1981-09-01 |
IL63664A0 (en) | 1981-11-30 |
JPS5798255A (en) | 1982-06-18 |
BE890116A (fr) | 1982-03-01 |
NL8103993A (nl) | 1982-03-16 |
NO812944L (no) | 1982-03-01 |
IT1137642B (it) | 1986-09-10 |
GB2083036A (en) | 1982-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX6869E (es) | Procedimiento para la preparacion de dibenzimidiazoazepinas | |
MX6802E (es) | Procedimiento para la preparacion de derivados carboestirilicos | |
ES502546A0 (es) | Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2 | |
AR228468A1 (es) | Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas | |
AR226202A1 (es) | Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas | |
MX160977A (es) | Procedimiento para la preparacion de cloroformiatos alfa-clorados | |
AR231537A1 (es) | Procedimiento para la preparacion de derivados de la piridazina | |
ES524997A0 (es) | Procedimiento para la preparacion de derivados de la desoxiuridina | |
AR227906A1 (es) | Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina | |
MX156087A (es) | Procedimiento para la preparacion de derivados de piperazino-2-pirimidinas | |
ES501535A0 (es) | Procedimiento para la preparacion de derivados de alquilfos-fonito | |
MX157777A (es) | Procedimiento para la preparacion de derivados de ascoclorina | |
ES501464A0 (es) | Procedimiento para la preparacion de nuevas fenilureas | |
ES499729A0 (es) | Procedimiento para la preparacion de derivados de fenoxi- aminopropanol | |
ES503407A0 (es) | Procedimiento para la preparacion de derivados de pirimidina | |
ES501736A0 (es) | Procedimiento para la preparacion de derivados de 2-guanidi-notiazol | |
ES503975A0 (es) | Procedimiento para la preparacion de nuevas fenilureas | |
ES502649A0 (es) | Procedimiento para la preparacion de derivados de fenoxi- aminopropanol substituidos | |
ES500959A0 (es) | Procedimiento para la preparacion de derivados de cianoal- quil-fenilurea | |
ES500892A0 (es) | Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano | |
ES505576A0 (es) | Procedimiento para la preparacion de derivados de 7-oxopros-taciclina | |
ES500071A0 (es) | Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les | |
ES499356A0 (es) | Procedimiento para la preparacion de derivados de rifamicina | |
AR229350A1 (es) | Procedimiento para la preparacion de nuevas guanilamidinas | |
ES534337A0 (es) | Procedimiento para la preparacion de derivados de acridanona |